Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,230.12
+0.3%
+21.11
Arrow-Thin-Down
DJI
49,499.27
-0.3%
-152.87
Arrow-Thin-Down
NASDAQ
25,114.44
+0.9%
+222.13
Arrow-Thin-Down
Bitcoin
$79,862.00
+1.7%
+$1,348.42
Arrow-Thin-Down
AAPL
$280.19
+3.3%
+$8.84
Arrow-Thin-Down
AMZN
$268.36
+1.2%
+$3.30
Arrow-Thin-Down
GOOG
$383.22
+0.3%
+$1.28
Arrow-Thin-Down
META
$608.57
-0.5%
-$3.34
Arrow-Thin-Down
MSFT
$414.40
+1.6%
+$6.62
Arrow-Thin-Down
NVDA
$198.61
-0.5%
-$0.96
Arrow-Thin-Down
TSLA
$390.97
+2.4%
+$9.34
Most Active StocksDaily Stock GainersDaily Stock Losers
Bioxyne logo

Bioxyne

(ASX) BXN

Current Price$0.06
Market Cap$131.69M
Since IPO (2012)-57%
5 Year+164%
1 Year+190%
1 Month-9%

Bioxyne Financials at a Glance

Market Cap

$131.69M

Revenue (TTM)

$66.36M

Net Income (TTM)

$11.20M

EPS (TTM)

$0.00

P/E Ratio

14.15

Dividend

$0.00

Beta (Volatility)

0.36 (Low)

Price

$0.06

Volume

1,247,933

Open

$0.06

Previous Close

$0.06

Daily Range

$0.06 - $0.06

52-Week Range

$0.02 - $0.08

BXN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bioxyne

Industry

Life Sciences Tools and Services

Sector

Health Care

CEO

Sam Watson

Website

www.bioxyne.com

Headquarters

Sydney, NSW 2000, AU

BXN Financials

Key Financial Metrics (TTM)

Gross Margin

33%

Operating Margin

19%

Net Income Margin

18%

Return on Equity

65%

Return on Capital

38%

Return on Assets

26%

Earnings Yield

7.07%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$131.69M

Shares Outstanding

2.27B

Volume

1.25M

Avg. Volume

3.94M

Financials (TTM)

Gross Profit

$10.45M

Operating Income

$5.56M

EBITDA

$5.34M

Operating Cash Flow

$6.28M

Capital Expenditure

$2.41M

Free Cash Flow

$3.86M

Cash & ST Invst.

$7.67M

Total Debt

$1.53M

Bioxyne Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$31.31M

+565.8%

Gross Profit

$12.17M

+943.7%

Gross Margin

38.88%

N/A

Market Cap

$131.69M

N/A

Market Cap/Employee

$8.23M

N/A

Employees

16

N/A

Net Income

$7.34M

+159.8%

EBITDA

$8.22M

+166.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$173.90K

-88.6%

Accounts Receivable

$6.01M

+368.3%

Inventory

$11.73M

+650.9%

Long Term Debt

$6.22M

N/A

Short Term Debt

$1.21M

N/A

Return on Assets

25.89%

N/A

Return on Invested Capital

37.75%

N/A

Free Cash Flow

$2.27M

-2.0%

Operating Cash Flow

$1.29M

+41.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EDU.AXEDU Holdings Limited
$0.82-2.96%
NZK.AXNew Zealand King Salmon Investments Limited
$0.19-5.00%
CLV.AXClover Corporation Limited
$0.97+0.00%
LRK.AXLARK Distilling Co. Ltd.
$0.89-1.67%

Trending Stocks

Symbol / CompanyPricePrice Chg
AAPLApple
$280.19+0.03%
TSLATesla
$390.97+0.02%
NOKNokia
$13.30+0.03%
AMZNAmazon
$268.36+0.01%

Questions About BXN

What is the current price of Bioxyne?

Bioxyne is trading at A$0.06 per share.

What is the 52-week range for Bioxyne?

Over the past 52 weeks, Bioxyne has traded between A$0.02 and A$0.08.

How much debt does Bioxyne have?

As of the most recent reporting period, Bioxyne reported total debt of $1.53M.

How much cash does Bioxyne have on hand?

Bioxyne reported $7.67M in cash and cash equivalents in its most recent financial results.

What is Bioxyne’s dividend yield?

Bioxyne does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services